Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 2,300 shares, a decline of 94.1% from the April 30th total of 39,000 shares. Approximately 0.0% of the shares of the company are short sold. […]
Carisma Therapeutics (NASDAQ:CARM – Get Rating) and Synaptogenix (NASDAQ:SNPX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability. Valuation & Earnings This table compares Carisma Therapeutics and Synaptogenix’s […]
Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the target of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 39,000 shares, a decrease of 87.6% from the April 15th total of 313,600 shares. Approximately 0.6% of the shares of the stock are short sold. […]
Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating)’s stock price traded down 1.3% on Tuesday . The stock traded as low as $0.75 and last traded at $0.79. 17,025 shares were traded during mid-day trading, a decline of 79% from the average session volume of 81,457 shares. The stock had previously closed at $0.80. Analyst Ratings Changes […]
/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics.